Cargando…
Engineering Factor Xa Inhibitor with Multiple Platelet-Binding Sites Facilitates its Platelet Targeting
Targeted delivery of antithrombotic drugs centralizes the effects in the thrombosis site and reduces the hemorrhage side effects in uninjured vessels. We have recently reported that the platelet-targeting factor Xa (FXa) inhibitors, constructed by engineering one Arg-Gly-Asp (RGD) motif into Ancylos...
Autores principales: | Zhu, Yuanjun, Li, Ruyi, Lin, Yuan, Shui, Mengyang, Liu, Xiaoyan, Chen, Huan, Wang, Yinye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949463/ https://www.ncbi.nlm.nih.gov/pubmed/27432161 http://dx.doi.org/10.1038/srep29895 |
Ejemplares similares
-
Evaluation of novel factor Xa inhibitors from Oxya chinensis sinuosa with anti-platelet aggregation activity
por: Lee, Wonhwa, et al.
Publicado: (2017) -
Design and evaluation of EphrinA1 mutants with cerebral protective effect
por: Zhu, Yuanjun, et al.
Publicado: (2017) -
Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors
por: Verhoef, Daniël, et al.
Publicado: (2017) -
Platelet-Derived Inhibitors of Platelet Activation
por: Unsworth, A. J., et al.
Publicado: (2017) -
Neuroprotective Effect of TAT-14-3-3ε Fusion Protein against Cerebral Ischemia/Reperfusion Injury in Rats
por: Zhu, Yuanjun, et al.
Publicado: (2014)